查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654143

临床诊断市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2024-2030 年

Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

临床诊断市场的成长和趋势

根据 Grand View Research, Inc. 的新报告，全球临床诊断市场规模预计到 2030 年将达到 1,692.3 亿美元，2024 年至 2030 年的复合年增长率为 6.6%。

市场成长的动力包括慢性病盛行率的不断上升、用于早期检测和疾病管理的专门测试的出现以及对实验室自动化的不断增长的需求。此外，照护现场诊断产品的快速应用带来了医疗保健产业分散化的趋势。政府投资的增加和对研发的持续重视将推动进一步的成长。

心血管疾病、糖尿病、癌症和呼吸系统疾病等慢性病的流行给全球医疗保健系统带来了巨大负担。早期准确的诊断对于有效管理这些疾病至关重要，因此增加了对先进诊断工具和技术的需求。早期发现和准确分期癌症对于成功治疗至关重要。临床诊断透过一系列技术，包括影像检查（电脑断层扫描、 MRI、 PET 扫描）、分子诊断（基因测试、液态切片）和肿瘤标记的免疫检测测定，在癌症筛检、诊断和监测中发挥至关重要的作用。此外，传染病检查领域新产品的采用也促进了市场的成长。例如，2021年3月，FDA透过紧急使用授权(EUA)核准了雅培的BinaxNOW COVID-19 Ag Card快速检测。这种横向流免疫检测旨在快速检测 COVID-19，它的可用性预计将推动对传染病检查产品的需求。

由于采用自动化技术来简化业务、提高准确性并缩短交货时间，市场正在快速转变。自动化可最大限度地降低错误风险、提高结果的精确度和准确性、并允许处理大量样本，从而提高吞吐量。创新自动化照护现场（POC）分析仪的采用有望推动其普及，因为它们提供了经济高效的测试，并且能够同时执行多项测试。因此，我们看到采用新产品的明显趋势，这一趋势由于疫情的爆发和支持新型检测的先进诊断设备的增加而加速。

对高效、可靠的诊断解决方案的需求日益增长，尤其是在新兴市场，这推动了对具有成本效益的自动免疫检测係统的需求。例如，2023年7月，Sysmex公司在Sysmex AACC展会上推出了全新全自动快速化学冷光免疫检测系统。将免疫检测分析仪与安全软体和实验室资讯系统（LIS）结合，管理员可以控制使用者存取等级并将资料传输到其他设备，实现无缝资料传输和云端运算。预计这些进步将在预测期内推动该领域的成长。

此外，政府也为临床诊断领域的研发投入了大量资金。此外，现在还可以以可负担的价格提供爱滋病和C型肝炎等慢性病的诊断测试。此外，新兴市场（尤其是中国和印度）对医疗服务的需求不断增长，这两个市场对临床检测的需求尚未得到满足，这为临床诊断行业的成长提供了丰厚的机会。

市场的主要企业包括雅培、碧迪 (BD)、西门子医疗、迈瑞医疗国际有限公司、罗氏公司、Sysmex Corporation、Bio-Rad Laboratories 和 Quest Diagnostics, Inc.这些公司正在推行各种策略倡议，包括产品发布和核准，以服务其全球客户。例如，2023 年 5 月，Becton Dickinson (BD) 的 BD Chiestra抗药性金黄色葡萄球菌(MRSA) 成像应用获得了 FDA 510(k) 批准，该应用利用人工智慧 (AI) 软体。这项技术创新预计将大大缩短检测结果的周转时间，成为传染病检查市场的宝贵补充。

临床诊断市场报告重点

  • 按产品划分，设备在 2023 年占据了最大的收入份额。设备在帮助医疗保健专业人员检测和监测疾病、指导治疗决策以及最终改善患者治疗效果方面发挥着至关重要的作用。
  • 根据应用，感染疾病占据市场主导地位，在 2023 年占据最大份额。这是由于技术创新和用于感染疾病检测的专用检测套组的日益普及。
  • 根据最终用途，医院部门在 2023 年占据最大的市场占有率。这是因为法医学和医院医学实验室对临床诊断的需求不断增加，包括疾病诊断、血球计数、非法药物使用检测、蛋白质分析、血型和治疗水平监测。
  • 北美是糖尿病、肥胖、呼吸系统疾病等慢性病发生率较高的地区。这些疾病需要定期监测和诊断测试，因此对先进的诊断工具和技术的需求增加。
  • 预计 2024 年至 2030 年期间亚太地区的复合年增长率将达到 9.0%，为最快的地区。这得归功于拥有创新设备製造能力和加速诊断研究能力的製造商的存在。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章临床诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床诊断市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章 临床诊断市场：按设备的估计和趋势分析

  • 2023 年及 2030 年设备市场占有率
  • 细分仪表板
  • 全球临床诊断市场前景（按设备）
  • 2018-2030 年市场规模、预测及趋势分析
  • 装置
    • 血气分析仪
    • 血液分析仪
    • 临床化学分析仪
    • 尿液分析仪
    • 凝血分析仪
    • 显微镜
    • 流式细胞仪
    • PCR
    • 定序设备
    • 酵素连结免疫吸附试验
    • 质谱仪
    • 自动盘式分析仪
    • 光强度
    • 离心机
    • 电泳试剂
    • 就地检验(POCT) 设备
    • 超音波设备
    • CT（电脑断层扫描）扫描仪
    • MRI
    • X光设备
    • 其他的
  • 试剂
    • Taq聚合酵素
    • MMLV RT
    • HIV RT
    • 热启动Taq聚合酵素
    • 联合国
    • RNase抑制剂
    • Bst聚合酵素
    • PCR 预混液
    • T7 RNA聚合酵素
    • Cas9酶
    • 酸性磷酸酶
    • 丙氨酸胺基转移酶
    • 淀粉酶
    • 血管收缩素转化酵素
    • 天门冬胺基转移酶
    • 胆碱酯酶
    • 肌酸激酶
    • γ-谷氨酰转移酶
    • 乳酸脱氢酵素
    • 列宁
    • 葡萄糖氧化酵素/葡萄糖去氢酵素
    • 尿素酶
    • 淀粉酶
    • 乳酸氧化酶
    • 辣根过氧化物
    • 麸胺酸氧化酶
    • 其他的
  • 软体和服务
    • 实验室资讯管理系统
    • 诊断影像软体
    • 资料分析软体
    • 体外诊断药品的品管
  • 套件和检测试剂

第 5 章 临床诊断市场：按应用进行的估计和趋势分析

  • 2023 年和 2030 年应用市场占有率
  • 细分仪表板
  • 全球临床诊断市场应用前景
  • 2018-2030 年市场规模、预测及趋势分析
  • 感染疾病
    • HIV
    • 困难梭状芽孢桿菌
    • HBV
    • 呼吸道融合细胞病毒（RSV）
    • 肺炎或链球菌感染疾病
    • 流感
    • HCV
    • MRSA
    • 结核病和抗药性结核病
    • HSV
    • COVID-19
    • 其他感染疾病
  • 肿瘤学
    • 乳癌
    • 大肠直肠癌
    • 子宫颈癌
    • 肺癌
    • 摄护腺癌
    • 皮肤癌
    • 血癌
    • 肾癌
    • 肝癌
    • 胰臟癌
    • 卵巢癌
    • 其他的
  • 心臟病学
  • 内分泌学
  • 肾臟病学
  • 自体免疫疾病
  • 血液学
  • 毒理学
  • 心臟病学
  • 神经病学

第六章临床诊断市场：依最终用途的估计与趋势分析

  • 2023 年及 2030 年终端用途市场占有率
  • 细分仪表板
  • 全球临床诊断市场前景（按最终用途划分）
  • 2018-2030 年市场规模、预测及趋势分析
  • 医院和诊所
    • 住院和门诊病人
    • 急诊室
  • 诊断实验室
    • 独立实验室
    • 参考实验室
  • 居家医疗
    • 家庭检测套组
    • 照护现场设备
  • 公共卫生筛检项目

第 7 章临床诊断市场：区域、估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太地区：SWOT 分析
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 2023 年主要企业的市场占有率分析
    • Abbott
    • bioMerieux SA
    • QuidelOrtho Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen
    • Sysmex Corporation
    • Charles River Laboratories
    • Quest Diagnostics Incorporated
    • BD.
Product Code: GVR-4-68040-495-3

Clinical Diagnostics Market Growth & Trends:

The global clinical diagnostics market size is expected to reach USD 169.23 billion by 2030, registering a CAGR of 6.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is propelled by the growing incidence of chronic diseases, the creation of specialized tests for early detection and disease management, and the rising demand for laboratory automation. Additionally, the rapid adoption of point-of-care diagnostic products has introduced a trend towards decentralization in the healthcare industry. Further growth is driven by increased government investments and ongoing R&D efforts.

The prevalence of chronic conditions, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders, pose a substantial burden on healthcare systems worldwide. Early and accurate diagnosis plays a crucial role in managing these diseases effectively, leading to an increased demand for advanced diagnostic tools and technologies. Early detection and accurate staging of cancer are crucial for successful treatment outcomes. Clinical diagnostics play a vital role in cancer screening, diagnosis, and monitoring through various techniques, including imaging tests (CT scans, MRI, PET scans), molecular diagnostics (genetic testing, liquid biopsies), and immunoassays for tumor markers. Furthermore, the introduction of new products in the field of infectious disease testing is contributing to the market's growth. For instance, in March 2021 FDA's Emergency Use Authorization (EUA) granted BinaxNOW COVID-19 Ag Card rapid test by Abbott's. This lateral flow immunoassay is designed for the rapid detection of COVID-19, and its availability is expected to increase demand for infectious disease testing products.

The market is undergoing a rapid transformation as it adopts automation technologies to streamline operations, enhance accuracy, and reduce turnaround time. Automation minimizes the risk of errors and improves the precision and accuracy of results, while also enabling the handling of large volumes of samples, resulting in increased throughput. The introduction of innovative automated point-of-care (POC) analyzers is expected to drive increased adoption, offering cost-effective testing and the ability to conduct multiple tests simultaneously. As a result, there has been a notable trend towards adopting novel products, which has been accelerated by the pandemic and the increased availability of advanced diagnostic instruments that support novel assays.

The demand for cost-effective automated immunoassay systems is on the rise, particularly in developing markets, where there is a growing need for efficient and reliable diagnostic solutions. For instance, in July 2023, Sysmex Corporation introduced a new fully automated and high-speed chemiluminescence immunoassay system in Sysmex AACC exhibition. The integration of security software and Laboratory Information Systems (LIS) with immunoassay analyzers enables administrators to control user access levels and transfer data to other devices, facilitating seamless data transfer and cloud computing. These advancements are expected to drive the growth of the segment over the forecast period.

Presence of government funding programs aimed at reducing the burden of chronic diseases, by funding various clinical trials aimed at, is expected to have a positive impact on the market, In addition governments are allocating substantial funds for research and development (R&D) in the field of clinical diagnostics. In addition, the availability of affordable diagnostic tests for chronic diseases such as AIDS and hepatitis C. Additionally, the rising demand for healthcare services in emerging markets, particularly China and India, where there is a significant unmet need for clinical testing, presents a lucrative opportunity for growth in the clinical diagnostics industry.

Some of the key players in the market are Abbott, Becton Dickinson (BD), Siemens Healthineers, Mindray Medical International Limited, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Bio-Rad Laboratories, and Quest Diagnostics Incorporated. These players are involved in various strategic initiatives such as product launch and approval in order to cater to a global clientele. For instance, in May 2023, Becton Dickinson (BD) received FDA 510(k) clearance for its BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) imaging application, which leverages artificial intelligence (AI) software. This innovation is expected to significantly reduce the turnaround time for test results, making it a valuable addition to the market for infectious disease testing.

Clinical Diagnostics Market Report Highlights:

  • Based on product, instruments accounted for the largest revenue share in 2023. Instruments play a crucial role in enabling healthcare professionals to detect and monitor diseases, guide treatment decisions, and ultimately improve patient outcomes.
  • Based on application, infectious diseases dominated the market and accounted for the largest share in 2023.This can be attributed to increasing innovation and availability of specialized test kits for infectious disease detection.
  • Based on end use, hospital segment dominated the end use segments with the largest market share in 2023. This is attributable to growing clinical diagnostics demand in forensic labs and hospital medical labs for disease diagnosis, blood cell counts, detecting illegal drug use, protein analysis, blood typing and monitoring therapeutic drug levels.
  • North America dominated the global market due to the presence of a large number of major market players, North America has a high prevalence of chronic diseases like diabetes, obesity, and respiratory conditions. These diseases require regular monitoring and diagnostic testing, fueling the demand for advanced diagnostic tools and technologies.
  • Asia Pacific is expected to witness the fastest CAGR of 9.0% from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Instruments
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increase in prevalence of chronic diseases
      • 3.2.1.2. Increasing demand for lab automation
      • 3.2.1.3. Development of specialized tests for early disease management
      • 3.2.1.4. Rapid growth of point of care diagnostic products
      • 3.2.1.5. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Clinical Diagnostics Instruments
  • 3.3. Clinical Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Clinical Diagnostics Market: Instruments Estimates & Trend Analysis

  • 4.1. Instruments Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Diagnostics Market by Instruments Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Blood gas analyzers
      • 4.5.2.1. Blood gas analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Hematology analyzers
      • 4.5.3.1. Hematology analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Clinical chemistry analyzers
      • 4.5.4.1. Clinical chemistry analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Urine analyzers
      • 4.5.5.1. Urine analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Coagulation analyzers
      • 4.5.6.1. Coagulation analyzers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.7. Microscopes
      • 4.5.7.1. Microscopes market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.8. Flow Cytometers
      • 4.5.8.1. Flow cytometers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.9. PCR
      • 4.5.9.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.10. Sequencing Instruments
      • 4.5.10.1. Sequencing Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.11. ELISA
      • 4.5.11.1. ELISA market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.12. Mass Spectrometers
      • 4.5.12.1. Mass Spectrometers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.13. Automated Plate Readers
      • 4.5.13.1. Automated plate readers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.14. Spectrophotometers
      • 4.5.14.1. Spectrophotometers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.15. Centrifuges
      • 4.5.15.1. Centrifuges market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.16. Electrophoresis Reagents
      • 4.5.16.1. Electrophoresis equipment market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.17. Point-of-Care Testing (POCT) Devices
      • 4.5.17.1. Point-of-Care testing (POCT) devices market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.18. Ultrasound Machines
      • 4.5.18.1. Ultrasound machines market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.19. CT (Computed Tomography) Scanners
      • 4.5.19.1. CT (Computed Tomography) scanners market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.20. MRI
      • 4.5.20.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.21. X-ray Machines
      • 4.5.21.1. X-ray Machines market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.22. Others
      • 4.5.22.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Reagents
    • 4.6.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Taq polymerase
      • 4.6.2.1. Taq polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. MMLV RT
      • 4.6.3.1. MMLV RT market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. HIV RT
      • 4.6.4.1. HIV RT market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Hot start Taq polymerase
      • 4.6.5.1. Hot start Taq polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. UNG
      • 4.6.6.1. UNG market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.7. RNase inhibitors
      • 4.6.7.1. RNase inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.8. Bst polymerase
      • 4.6.8.1. Bst polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.9. PCR master mix
      • 4.6.9.1. PCR master mix market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.10. T7 RNA polymerase
      • 4.6.10.1. T7 RNA polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.11. Cas9 enzyme
      • 4.6.11.1. Cas9 enzyme market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.12. Acid Phosphatase
      • 4.6.12.1. Acid Phosphatase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.13. Alanine aminotransferase
      • 4.6.13.1. Alanine aminotransferase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.14. Amylase
      • 4.6.14.1. Amylase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.15. Angiotensin converting enzyme
      • 4.6.15.1. Angiotensin converting enzyme market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.16. Aspartate aminotransferase
      • 4.6.16.1. Aspartate aminotransferase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.17. Cholinesterase
      • 4.6.17.1. Cholinesterase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.18. Creatinine kinase
      • 4.6.18.1. Creatinine kinase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.19. Gamma glutamyl transferase
      • 4.6.19.1. Gamma glutamyl transferase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.20. Lactate dehydrogenase
      • 4.6.20.1. Lactate dehydrogenase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.21. Renin
      • 4.6.21.1. Renin market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.22. Glucose oxidase/glucose dehydrogenase
      • 4.6.22.1. Glucose oxidase/glucose dehydrogenase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.23. Urease
      • 4.6.23.1. Urease market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.24. Amylase
      • 4.6.24.1. Amylase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.25. Lactate oxidase
      • 4.6.25.1. Lactate oxidase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.26. Horseradish peroxide
      • 4.6.26.1. Horseradish peroxide market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.27. Glutamate Oxidase
      • 4.6.27.1. Glutamate Oxidase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.28. Others
      • 4.6.28.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software and Services
    • 4.7.1. Software and Services market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Laboratory information management systems
      • 4.7.2.1. Laboratory information management systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. Diagnostic imaging software
      • 4.7.3.1. Diagnostic imaging software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.4. Data analysis software
      • 4.7.4.1. Data analysis software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.5. In Vitro Diagnostics Quality Control
      • 4.7.5.1. In Vitro Diagnostics Quality Control market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Kits and assays
    • 4.8.1. Kits and assays market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Diagnostics Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Infectious Disease
    • 5.5.1. Infectious disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. HIV
      • 5.5.2.1. HIV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Clostridium Difficile
      • 5.5.3.1. Clostridium Difficile Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. HBV
      • 5.5.4.1. HBV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Respiratory Syncytial Virus (RSV)
      • 5.5.5.1. Respiratory Syncytial Virus (RSV) Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Pneumonia or Streptococcus Associated Infections
      • 5.5.6.1. Respiratory Syncytial Virus (RSV) Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Influenza/Flu
      • 5.5.7.1. Influenza/Flu Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.8. HCV
      • 5.5.8.1. HCV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.9. MRSA
      • 5.5.9.1. MRSA Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.10. TB and Drug-resistant TB
      • 5.5.10.1. TB and Drug-resistant TB Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.11. HSV
      • 5.5.11.1. HSV Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.12. COVID-19
      • 5.5.12.1. COVID-19 Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.13. Other Infectious Diseases
      • 5.5.13.1. Other Infectious Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Breast Cancer
      • 5.6.2.1. Breast Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Colorectal Cancer
      • 5.6.3.1. Colorectal Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Cervical Cancer
      • 5.6.4.1. Cervical Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Lung Cancer
      • 5.6.5.1. Lung Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Prostate Cancer
      • 5.6.6.1. Prostate Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.7. Skin Cancer
      • 5.6.7.1. Skin Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.8. Blood Cancer
      • 5.6.8.1. Blood Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.9. Kidney Cancer
      • 5.6.9.1. Kidney Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.10. Liver Cancer
      • 5.6.10.1. Liver Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.11. Pancreatic Cancer
      • 5.6.11.1. Pancreatic cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.12. Ovarian Cancer
      • 5.6.12.1. Ovarian Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.13. Others
      • 5.6.13.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Cardiology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Endocrinology
    • 5.8.1. Endocrinology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Nephrology
    • 5.9.1. Nephrology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.11. Hematology
    • 5.11.1. Hematology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.12. Toxicology
    • 5.12.1. Toxicology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.13. Cardiology
    • 5.13.1. Cardiology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.14. Neurology
    • 5.14.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Diagnostics Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & Clinics Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Inpatient and Outpatient
      • 6.5.2.1. Inpatient and Outpatient Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Emergency Rooms
      • 6.5.3.1. Emergency Rooms Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Laboratories
    • 6.6.1. Diagnostic Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Independent Laboratories
      • 6.6.2.1. Independent Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Reference Laboratories
      • 6.6.3.1. Reference Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Home Care Settings
    • 6.7.1. Home Care Settings Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. At-home Testing Kits
      • 6.7.2.1. At-home Testing Kits Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. Point-of-Care Devices
      • 6.7.3.1. Point-of-Care Devices Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Public Health Screening Programs
    • 6.8.1. Public Health Screening Programs Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific: SWOT Analysis
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Services benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. bioMerieux SA
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Services benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. QuidelOrtho Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Services benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Siemens Healthineers AG
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Services benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Thermo Fisher Scientific, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Services benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Agilent Technologies, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Services benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Bio-Rad Laboratories, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Services benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Qiagen
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Services benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Sysmex Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Services benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Charles River Laboratories
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Services benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Quest Diagnostics Incorporated
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Services benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. BD.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Services benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 15 Europe Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 18 Germany Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 21 UK Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 France Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 24 France Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 27 Italy Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 30 Spain Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 33 Denmark Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 39 Norway Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 China Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 46 China Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 49 Japan Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 India Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 52 India Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 South Korea Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 South Korea Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 55 South Korea Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 58 Australia Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 64 Latin America Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Brazil Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 66 Brazil Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 67 Brazil Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Mexico Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 69 Mexico Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 70 Mexico Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 73 Argentina Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA Clinical diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 77 MEA Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 80 South Africa Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 86 UAE Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait Clinical diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Clinical diagnostics market, application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Clinical diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Diagnostics, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global clinical diagnostics market, for Product, 2018 - 2030 (USD Million)
  • Fig. 13 Global clinical diagnostics market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 14 Global clinical diagnostics market, for Blood gas analyzers, 2018 - 2030 (USD Million)
  • Fig. 15 Global clinical diagnostics market, for Hematology analyzers, 2018 - 2030 (USD Million)
  • Fig. 16 Global clinical diagnostics market, for Clinical chemistry analyzers, 2018 - 2030 (USD Million)
  • Fig. 17 Global clinical diagnostics market, for Immunoassay analyzers, 2018 - 2030 (USD Million)
  • Fig. 18 Global clinical diagnostics market, for Urine analyzers, 2018 - 2030 (USD Million)
  • Fig. 19 Global clinical diagnostics market, for Coagulation analyzers, 2018 - 2030 (USD Million)
  • Fig. 20 Global clinical diagnostics market, for Microscopes, 2018 - 2030 (USD Million)
  • Fig. 21 Global clinical diagnostics market, for Flow cytometers, 2018 - 2030 (USD Million)
  • Fig. 22 Global clinical diagnostics market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 23 Global clinical diagnostics market, for Sequencing instruments, 2018 - 2030 (USD Million)
  • Fig. 24 Global clinical diagnostics market, for Elisa, 2018 - 2030 (USD Million)
  • Fig. 25 Global clinical diagnostics market, for Mass spectrometers, 2018 - 2030 (USD Million)
  • Fig. 26 Global clinical diagnostics market, for Automated plate readers, 2018 - 2030 (USD Million)
  • Fig. 27 Global clinical diagnostics market, for Spectrophotometers, 2018 - 2030 (USD Million)
  • Fig. 28 Global clinical diagnostics market, for Centrifuges, 2018 - 2030 (USD Million)
  • Fig. 29 Global clinical diagnostics market, for Electrophoresis equipment, 2018 - 2030 (USD Million)
  • Fig. 30 Global clinical diagnostics market, for Point-of-care testing (POCT) devices, 2018 - 2030 (USD Million)
  • Fig. 31 Global clinical diagnostics market, for Ultrasound machines, 2018 - 2030 (USD Million)
  • Fig. 32 Global clinical diagnostics market, for Ct (computed tomography) scanners, 2018 - 2030 (USD Million)
  • Fig. 33 Global clinical diagnostics market, for MRI, 2018 - 2030 (USD Million)
  • Fig. 34 Global clinical diagnostics market, for X-ray machines, 2018 - 2030 (USD Million)
  • Fig. 35 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 36 Global clinical diagnostics market, for Reagents, 2018 - 2030 (USD Million)
  • Fig. 37 Global clinical diagnostics market, for Taq polymerase, 2018 - 2030 (USD Million)
  • Fig. 38 Global clinical diagnostics market, for MMLV RT, 2018 - 2030 (USD Million)
  • Fig. 39 Global clinical diagnostics market, for HIV RT, 2018 - 2030 (USD Million)
  • Fig. 40 Global clinical diagnostics market, for Hot start taq polymerase, 2018 - 2030 (USD Million)
  • Fig. 41 Global clinical diagnostics market, for Ung, 2018 - 2030 (USD Million)
  • Fig. 42 Global clinical diagnostics market, for RNAse inhibitors, 2018 - 2030 (USD Million)
  • Fig. 43 Global clinical diagnostics market, for BST polymerase, 2018 - 2030 (USD Million)
  • Fig. 44 Global clinical diagnostics market, for PCR master mix, 2018 - 2030 (USD Million)
  • Fig. 45 Global clinical diagnostics market, for Lyophilized polymerase, 2018 - 2030 (USD Million)
  • Fig. 46 Global clinical diagnostics market, for T7 RNA polymerase, 2018 - 2030 (USD Million)
  • Fig. 47 Global clinical diagnostics market, for Cas9 enzyme, 2018 - 2030 (USD Million)
  • Fig. 48 Global clinical diagnostics market, for Acid phosphatase, 2018 - 2030 (USD Million)
  • Fig. 49 Global clinical diagnostics market, for Alanine aminotransferase, 2018 - 2030 (USD Million)
  • Fig. 50 Global clinical diagnostics market, for Amylase, 2018 - 2030 (USD Million)
  • Fig. 51 Global clinical diagnostics market, for Angiotensin converting enzyme, 2018 - 2030 (USD Million)
  • Fig. 52 Global clinical diagnostics market, for Aspartate aminotransferase, 2018 - 2030 (USD Million)
  • Fig. 53 Global clinical diagnostics market, for Cholinesterase, 2018 - 2030 (USD Million)
  • Fig. 54 Global clinical diagnostics market, for Creatinine kinase, 2018 - 2030 (USD Million)
  • Fig. 55 Global clinical diagnostics market, for Gamma glutamyl transferase, 2018 - 2030 (USD Million)
  • Fig. 56 Global clinical diagnostics market, for Lactate dehydrogenase, 2018 - 2030 (USD Million)
  • Fig. 57 Global clinical diagnostics market, for Renin, 2018 - 2030 (USD Million)
  • Fig. 58 Global clinical diagnostics market, for Glucose oxidase/glucose dehydrogenase, 2018 - 2030 (USD Million)
  • Fig. 59 Global clinical diagnostics market, for Urease, 2018 - 2030 (USD Million)
  • Fig. 60 Global clinical diagnostics market, for Lactate oxidase, 2018 - 2030 (USD Million)
  • Fig. 61 Global clinical diagnostics market, for Horseradish peroxide, 2018 - 2030 (USD Million)
  • Fig. 62 Global clinical diagnostics market, for Glutamate oxidase, 2018 - 2030 (USD Million)
  • Fig. 63 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 64 Global clinical diagnostics market, for Software and services, 2018 - 2030 (USD Million)
  • Fig. 65 Global clinical diagnostics market, for Laboratory information management systems, 2018 - 2030 (USD Million)
  • Fig. 66 Global clinical diagnostics market, for Diagnostic imaging software, 2018 - 2030 (USD Million)
  • Fig. 67 Global clinical diagnostics market, for Data analysis software, 2018 - 2030 (USD Million)
  • Fig. 68 Global clinical diagnostics market, for In vitro diagnostics quality control, 2018 - 2030 (USD Million)
  • Fig. 69 Global clinical diagnostics market, for Kits and assays, 2018 - 2030 (USD Million)
  • Fig. 70 Global clinical diagnostics market, for Application, 2018 - 2030 (USD Million)
  • Fig. 71 Global clinical diagnostics market, for Infectious diseases, 2018 - 2030 (USD Million)
  • Fig. 72 Global clinical diagnostics market, for HIV, 2018 - 2030 (USD Million)
  • Fig. 73 Global clinical diagnostics market, for Clostridium difficile, 2018 - 2030 (USD Million)
  • Fig. 74 Global clinical diagnostics market, for HBV, 2018 - 2030 (USD Million)
  • Fig. 75 Global clinical diagnostics market, for Pneumonia or Streptococcus Associated Infections, 2018 - 2030 (USD Million)
  • Fig. 76 Global clinical diagnostics market, for Respiratory Syncytial Virus (RSV), 2018 - 2030 (USD Million)
  • Fig. 77 Global clinical diagnostics market, for HPV, 2018 - 2030 (USD Million)
  • Fig. 78 Global clinical diagnostics market, for Influenza/Flu, 2018 - 2030 (USD Million)
  • Fig. 79 Global clinical diagnostics market, for HCV, 2018 - 2030 (USD Million)
  • Fig. 80 Global clinical diagnostics market, for MRSA, 2018 - 2030 (USD Million)
  • Fig. 81 Global clinical diagnostics market, for TB and drug-resistant TB, 2018 - 2030 (USD Million)
  • Fig. 82 Global clinical diagnostics market, for HSV, 2018 - 2030 (USD Million)
  • Fig. 83 Global clinical diagnostics market, for COVID-19, 2018 - 2030 (USD Million)
  • Fig. 84 Global clinical diagnostics market, for Other infectious diseases, 2018 - 2030 (USD Million)
  • Fig. 85 Global clinical diagnostics market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 86 Global clinical diagnostics market, for Breast cancer, 2018 - 2030 (USD Million)
  • Fig. 87 Global clinical diagnostics market, for Colorectal cancer, 2018 - 2030 (USD Million)
  • Fig. 88 Global clinical diagnostics market, for Cervical cancer, 2018 - 2030 (USD Million)
  • Fig. 89 Global clinical diagnostics market, for Lung cancer, 2018 - 2030 (USD Million)
  • Fig. 90 Global clinical diagnostics market, for Prostate cancer, 2018 - 2030 (USD Million)
  • Fig. 91 Global clinical diagnostics market, for Skin cancer, 2018 - 2030 (USD Million)
  • Fig. 92 Global clinical diagnostics market, for Blood cancer, 2018 - 2030 (USD Million)
  • Fig. 93 Global clinical diagnostics market, for Kidney cancer, 2018 - 2030 (USD Million)
  • Fig. 94 Global clinical diagnostics market, for Liver cancer, 2018 - 2030 (USD Million)
  • Fig. 95 Global clinical diagnostics market, for Pancreatic cancer, 2018 - 2030 (USD Million)
  • Fig. 96 Global clinical diagnostics market, for Ovarian cancer, 2018 - 2030 (USD Million)
  • Fig. 97 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 98 Global clinical diagnostics market, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 99 Global clinical diagnostics market, for Endocrinology, 2018 - 2030 (USD Million)
  • Fig. 100 Global clinical diagnostics market, for Nephrology, 2018 - 2030 (USD Million)
  • Fig. 101 Global clinical diagnostics market, for Autoimmune diseases, 2018 - 2030 (USD Million)
  • Fig. 102 Global clinical diagnostics market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 103 Global clinical diagnostics market, for Toxicology, 2018 - 2030 (USD Million)
  • Fig. 104 Global clinical diagnostics market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 105 Global clinical diagnostics market, for Others, 2018 - 2030 (USD Million)
  • Fig. 106 Global clinical diagnostics market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 107 Global clinical diagnostics market, for Hospitals and Clinics, 2018 - 2030 (USD Million)
  • Fig. 108 Global clinical diagnostics market, for Inpatient and Outpatient, 2018 - 2030 (USD Million)
  • Fig. 109 Global clinical diagnostics market, for Emergency Rooms, 2018 - 2030 (USD Million)
  • Fig. 110 Global clinical diagnostics market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 111 Global clinical diagnostics market, for Independent Laboratories, 2018 - 2030 (USD Million)
  • Fig. 112 Global clinical diagnostics market, Reference Laboratories 2018 - 2030 (USD Million)
  • Fig. 113 Global clinical diagnostics market, Home Care Settings 2018 - 2030 (USD Million)
  • Fig. 114 Global clinical diagnostics market, At-home Testing Kits 2018 - 2030 (USD Million)
  • Fig. 115 Global clinical diagnostics market, Point-of-Care Devices 2018 - 2030 (USD Million)
  • Fig. 116 Global clinical diagnostics market, Public Health Screening Programs 2018 - 2030 (USD Million)
  • Fig. 117 Regional Outlook, 2023 & 2030
  • Fig. 118 North America Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 U.S. Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Canada Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Mexico Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Europe Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 123 Germany Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 124 UK Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 125 France Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 126 Italy Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Spain Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Denmark Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Sweden Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 130 Norway Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 131 Asia Pacific Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 132 Japan Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 133 China Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 134 India Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 135 Australia Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 136 South Korea Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 137 Thailand Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 138 Latin America Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 139 Brazil Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 140 Argentina Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 141 Middle East and Africa Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 142 South Africa Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 143 Saudi Arabia Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 144 UAE Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 145 Kuwait Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)